Approaches to the problem of individual doxorubicin dosing schedules.

Abstract

Doxorubicin is one of the most commonly used antineoplastic agents today. Dosing schedules are inexact and there remains a need to develop predictive models for its administration. Data from prior work in humans is difficult to interpret because of poor patient selection, poor drug assays, lack of knowledge of metabolite toxicity, concurrent treatment with… (More)

Topics

Cite this paper

@article{Brenner1987ApproachesTT, title={Approaches to the problem of individual doxorubicin dosing schedules.}, author={Dean E. Brenner}, journal={Pathologie-biologie}, year={1987}, volume={35 1}, pages={31-9} }